Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Crit Care Med ; 46(8): e742-e750, 2018 08.
Article in English | MEDLINE | ID: mdl-29727370

ABSTRACT

OBJECTIVES: The aim of this study was to evaluate the efficacy of perioperative intra-aortic balloon pump use in high-risk cardiac surgery patients. DESIGN: A single-center randomized controlled trial and a meta-analysis of randomized controlled trials. SETTING: Heart Institute of São Paulo University. PATIENTS: High-risk patients undergoing elective coronary artery bypass surgery. INTERVENTION: Patients were randomized to receive preskin incision intra-aortic balloon pump insertion after anesthesia induction versus no intra-aortic balloon pump use. MEASUREMENTS AND MAIN RESULTS: The primary outcome was a composite endpoint of 30-day mortality and major morbidity (cardiogenic shock, stroke, acute renal failure, mediastinitis, prolonged mechanical ventilation, and a need for reoperation). A total of 181 patients (mean [SD] age 65.4 [9.4] yr; 32% female) were randomized. The primary outcome was observed in 43 patients (47.8%) in the intra-aortic balloon pump group and 42 patients (46.2%) in the control group (p = 0.46). The median duration of inotrope use (51 hr [interquartile range, 32-94 hr] vs 39 hr [interquartile range, 25-66 hr]; p = 0.007) and the ICU length of stay (5 d [interquartile range, 3-8 d] vs 4 d [interquartile range, 3-6 d]; p = 0.035) were longer in the intra-aortic balloon pump group than in the control group. A meta-analysis of 11 randomized controlled trials confirmed a lack of survival improvement in high-risk cardiac surgery patients with perioperative intra-aortic balloon pump use. CONCLUSIONS: In high-risk patients undergoing cardiac surgery, the perioperative use of an intra-aortic balloon pump did not reduce the occurrence of a composite outcome of 30-day mortality and major complications compared with usual care alone.


Subject(s)
Cardiac Surgical Procedures/mortality , Cardiac Surgical Procedures/methods , Intra-Aortic Balloon Pumping/methods , Postoperative Complications/epidemiology , Aged , Cardiotonic Agents/administration & dosage , Female , Humans , Intensive Care Units , Length of Stay , Male , Middle Aged , Postoperative Complications/mortality , Risk Factors , Single-Blind Method
2.
J Cardiothorac Vasc Anesth ; 32(6): 2512-2519, 2018 Dec.
Article in English | MEDLINE | ID: mdl-29703580

ABSTRACT

OBJECTIVES: To investigate the efficacy and safety of perioperative administration of nitric oxide in cardiac surgery. DESIGN: Meta-analysis of randomized controlled trials (RCTs). PARTICIPANTS: Cardiac surgery patients. INTERVENTIONS: A search of Cochrane Central Register of Controlled Trials (CENTRAL), Embase, and MEDLINE for RCTs that compared nitric oxide with placebo or other comparators. MEASUREMENTS AND MAIN RESULTS: The primary outcome was intensive care unit (ICU) stay, and secondary outcomes were mortality, duration of mechanical ventilation, and reduction of mean pulmonary artery pressure. The study included 18 RCTs comprising 958 patients. The authors calculated the pooled odds ratio (OR) and the mean difference (MD) with random-effects model. Quantitative synthesis of data demonstrated a clinically negligible reduction in the length of ICU stay (MD -0.38 days, confidence interval CI [-0.65 to -0.11]; p = 0.005) and mechanical ventilation duration (MD -4.81 hours, CI [-7.79 to -1.83]; p = 0.002) compared with all control interventions with no benefit on mortality. CONCLUSIONS: Perioperative delivery of inhaled nitric oxide resulted to be of no or minimal benefit in patients with pulmonary hypertension undergoing cardiac surgery. Large, randomized trials are needed to further assess its effect on major clinical outcomes and its cost-effectiveness.


Subject(s)
Cardiac Surgical Procedures , Heart Diseases/surgery , Hypertension, Pulmonary/drug therapy , Nitric Oxide/administration & dosage , Perioperative Care/methods , Pulmonary Wedge Pressure/drug effects , Randomized Controlled Trials as Topic , Administration, Inhalation , Endothelium-Dependent Relaxing Factors/administration & dosage , Heart Diseases/complications , Heart Diseases/physiopathology , Humans , Hypertension, Pulmonary/etiology , Hypertension, Pulmonary/physiopathology , Treatment Outcome
3.
JAMA ; 317(14): 1422-1432, 2017 04 11.
Article in English | MEDLINE | ID: mdl-28322416

ABSTRACT

Importance: Perioperative lung-protective ventilation has been recommended to reduce pulmonary complications after cardiac surgery. The protective role of a small tidal volume (VT) has been established, whereas the added protection afforded by alveolar recruiting strategies remains controversial. Objective: To determine whether an intensive alveolar recruitment strategy could reduce postoperative pulmonary complications, when added to a protective ventilation with small VT. Design, Setting, and Participants: Randomized clinical trial of patients with hypoxemia after cardiac surgery at a single ICU in Brazil (December 2011-2014). Interventions: Intensive recruitment strategy (n=157) or moderate recruitment strategy (n=163) plus protective ventilation with small VT. Main Outcomes and Measures: Severity of postoperative pulmonary complications computed until hospital discharge, analyzed with a common odds ratio (OR) to detect ordinal shift in distribution of pulmonary complication severity score (0-to-5 scale, 0, no complications; 5, death). Prespecified secondary outcomes were length of stay in the ICU and hospital, incidence of barotrauma, and hospital mortality. Results: All 320 patients (median age, 62 years; IQR, 56-69 years; 125 women [39%]) completed the trial. The intensive recruitment strategy group had a mean 1.8 (95% CI, 1.7 to 2.0) and a median 1.7 (IQR, 1.0-2.0) pulmonary complications score vs 2.1 (95% CI, 2.0-2.3) and 2.0 (IQR, 1.5-3.0) for the moderate strategy group. Overall, the distribution of primary outcome scores shifted consistently in favor of the intensive strategy, with a common OR for lower scores of 1.86 (95% CI, 1.22 to 2.83; P = .003). The mean hospital stay for the moderate group was 12.4 days vs 10.9 days in the intensive group (absolute difference, -1.5 days; 95% CI, -3.1 to -0.3; P = .04). The mean ICU stay for the moderate group was 4.8 days vs 3.8 days for the intensive group (absolute difference, -1.0 days; 95% CI, -1.6 to -0.2; P = .01). Hospital mortality (2.5% in the intensive group vs 4.9% in the moderate group; absolute difference, -2.4%, 95% CI, -7.1% to 2.2%) and barotrauma incidence (0% in the intensive group vs 0.6% in the moderate group; absolute difference, -0.6%; 95% CI, -1.8% to 0.6%; P = .51) did not differ significantly between groups. Conclusions and Relevance: Among patients with hypoxemia after cardiac surgery, the use of an intensive vs a moderate alveolar recruitment strategy resulted in less severe pulmonary complications while in the hospital. Trial Registration: clinicaltrials.gov Identifier: NCT01502332.


Subject(s)
Cardiac Surgical Procedures/adverse effects , Hypoxia/therapy , Oxygen Inhalation Therapy/methods , Postoperative Complications/therapy , Pulmonary Alveoli/physiology , Respiration, Artificial/methods , Severity of Illness Index , Aged , Barotrauma/epidemiology , Blood Pressure/physiology , Critical Care/statistics & numerical data , Female , Heart Rate/physiology , Hospital Mortality , Humans , Hypoxia/etiology , Incidence , Length of Stay , Lung Diseases/prevention & control , Male , Middle Aged , Odds Ratio , Oxygen Inhalation Therapy/statistics & numerical data , Partial Pressure , Positive-Pressure Respiration/methods , Postoperative Complications/prevention & control , Tidal Volume
4.
J Cardiothorac Surg ; 7: 58, 2012 Jun 22.
Article in English | MEDLINE | ID: mdl-22726992

ABSTRACT

OBJECTIVE: This case report describes an unusual presentation of right upper lobe atelectasis associated with refractory hypoxemia to conventional alveolar recruitment maneuvers in a patient soon after coronary artery bypass grafting surgery. METHOD: Case-report. RESULTS: The alveolar recruitment with PEEP = 40 cm H2O improved the patient's atelectasis and hypoxemia. CONCLUSION: In the present report, the unusual alveolar recruitment maneuver with PEEP 40 cm H2O showed to be safe and efficient to reverse refractory hypoxemia and uncommon atelectasis in a patient after cardiac surgery.


Subject(s)
Coronary Artery Bypass/adverse effects , Hypoxia/therapy , Positive-Pressure Respiration/methods , Postoperative Complications/therapy , Pulmonary Atelectasis/therapy , Pulmonary Surgical Procedures/methods , Humans , Hypoxia/etiology , Male , Middle Aged , Pulmonary Atelectasis/etiology , Radiography, Thoracic
SELECTION OF CITATIONS
SEARCH DETAIL
...